Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TAK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Takeda Pharmaceutical Company Limited stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on May 09, 2024)

Hold candidate since May 09, 2024 PDF

The Takeda Pharmaceutical Company Limited stock price gained 2.37% on the last trading day (Thursday, 9th May 2024), rising from $13.06 to $13.37. During the last trading day the stock fluctuated 5.48% from a day low at $12.77 to a day high of $13.47. The price has been going up and down for this period, and there has been a 2.3% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $39.33 million.

The stock lies the upper part of a falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $13.48 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -12.45% during the next 3 months and, with a 90% probability hold a price between $11.16 and $11.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TAK Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 2.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Takeda Pharmaceutical Company Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.49. On a fall, the stock will find some support from the short-term average at $13.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Takeda Pharmaceutical Company Limited stock

Takeda Pharmaceutical Company Limited finds support from accumulated volume at $13.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.700 between high and low, or 5.48%. For the last week the stock has had daily average volatility of 1.64%.

Our recommended stop-loss: $12.66 (-5.35%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (TAK) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Takeda Pharmaceutical Company Limited to open at $13.20, and during the day (based on 14 day Average True Range), to move between $13.17 and $13.57, which gives a possible trading interval of +/-$0.196 (+/-1.47%) up or down from last closing price. If Takeda Pharmaceutical Company Limited takes out the full calculated possible swing range there will be an estimated 2.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.36 (0.07%) than the resistance at $13.67 (2.24%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Takeda Pharmaceutical Company Limited stock A Buy?

Takeda Pharmaceutical Company Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.340 Hold/Accumulate Upgraded

Predicted Opening Price for Takeda Pharmaceutical Company Limited of Friday, May 10, 2024

Fair opening price May 10, 2024 Current price
$13.20 ( 1.25%) $13.37

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TAK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.90 3.99 %
R2 13.64 1.99 %
R1 13.47 0.753 %
Current price: 13.37
Support S1 12.94 -3.25 %
S2 12.77 -4.48 %
S3 12.50 -6.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.62 9.35 %
R2 14.34 7.26 %
R1 13.67 2.24 %
Current price 13.37
Support S1 13.36 -0.0748%
S2 13.28 -0.673%
S3 13.23 -1.05%

TAK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 27, 2024 Mar 27, 2024 Mar 27, 2024 $0.301 2.12%
2 Sep 13, 2023 Sep 28, 2023 Dec 11, 2023 $0.260 1.85%
3 Sep 13, 2022 Sep 29, 2022 Dec 12, 2022 $0.270 1.81%
4 Sep 29, 2021 Sep 29, 2021 Dec 13, 2021 $0.397 2.94%
5 Mar 15, 2021 Mar 30, 2021 Jul 12, 2021 $0.407 2.44%

FAQ

What is the symbol for Takeda Pharmaceutical Company Limited Stock and on which exchange is it traded?
The symbol for Takeda Pharmaceutical Company Limited is TAK and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Takeda Pharmaceutical Company Limited Stock.

What's the current price of Takeda Pharmaceutical Company Limited Stock?
As of the end of day on the May 09, 2024, the price of an Takeda Pharmaceutical Company Limited (TAK) share was $13.37.

What is the 52-week high and low for Takeda Pharmaceutical Company Limited Stock?
The 52-week high for Takeda Pharmaceutical Company Limited Stock is $17.03 and the 52-week low is $12.77.

What is the market capitalization of Takeda Pharmaceutical Company Limited Stock?
As of the May 09, 2024, the market capitalization of Takeda Pharmaceutical Company Limited is 40.981B.

When is the next earnings date for Takeda Pharmaceutical Company Limited?
The upcoming earnings date for Takeda Pharmaceutical Company Limited is Oct 31, 2024.
Click to get the best stock tips daily for free!

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Reves... TAK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT